Heron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to Say

Heron Therapeutics (HRTX) reported $40.59 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 0.5%. EPS of -$0.02 for the same period compares to $0.02 a year ago.The reported revenue represents no surprise over the Zacks Consensus Estimate of $0 million. With the consensus EPS estimate being -$0.03, the EPS surprise was +33.33%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine t ...